Brief: Medesis Pharma H1 Operating Loss Widens To 1.8 Million Euros
Oct 25 (Reuters) - Medesis Pharma SA ALMDP.PA :
* H1 2022 RESULTS
* H1 OPERATING LOSS EUR 1.8 MILLION VERSUS LOSS EUR 1.4
MILLION
YEAR AGO
* H1 NET REVENUE EUR 0.0 VERSUS EUR 73,050 YEAR AGO
* DEBT AT END JUNE EUR 2.3 MILLION
* H1 ACCOUNTING NET LOSS EUR 1.6 MLN VS LOSS EUR 1.1 MLN YR
AGO
Source text for Eikon: ID:nNDL4S6l7L
Further company coverage: ALMDP.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Medesis Pharma SA
See all newsBrief: Medesis Pharma FY EBIT Loss Widens To EUR 3.244 Mln
Brief: Medesis Pharma Signs A Partnership With Partner International
Brief: Medesis Pharma Issues Bond Financing With Maximum Potential Nominal Amount Of EUR 2.5 Mln
Brief: Medesis Pharma Creates Council For Neurodegenerative Diseases
Brief: Medesis Pharma H1 Operating Loss Widens To 1.8 Million Euros